IDEAYA Biosciences, Inc.
NASDAQ:IDYA
25.61 (USD) • At close December 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | IDEAYA Biosciences, Inc. |
Symbool | IDYA |
Munteenheid | USD |
Prijs | 25.61 |
Beurswaarde | 2,213,518,398 |
Dividendpercentage | 0% |
52-weken bereik | 24.475 - 47.735 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Yujiro S. Hata |
Website | https://www.ideayabio.com |
An error occurred while fetching data.
Over IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)